PubHive streamlines pharmacovigilance inefficiencies with AI-powered automation, enhancing operational efficiency and compliance and replacing trackers while delivering cost-effective solutions backed by over 20 years of industry expertise, going to present at the World Drug Safety Congress in Amsterdam

London, October 06, 2024 - PubHive Ltd., a leading provider of an AI-powered enterprise scientific literature management and safety Information Workflow Platform for pre-market and post-market surveillance, service providers / CROs, regulatory compliance, and signal management, proudly announces its role as a Gold Sponsor at the upcoming World Drug Safety Congress, to be held on October 9th and 10th in Amsterdam. This prestigious event gathers global pharmaceutical and healthcare professionals to discuss advancements and challenges in drug safety and pharmacovigilance.

PubHive's unique platform streamlines the complexities associated with post-market literature monitoring, safety and regulatory compliance, and aggregate reporting. With its cutting-edge tools, such as PubHive Navigator for global and local literature management, Aggregate Safety Reporting Hub for comprehensive safety reporting, and Signal Management for proactive signal detection, PubHive empowers organizations to enhance operational efficiencies and stay ahead in compliance.

During the congress, Raj Vaghela, CEO at PubHive, will deliver a pivotal presentation on "Automated and Centralized Approach to Enhance Signal Detection and Surveillance Efficiency for SMEs." Scheduled for October 10th at 12:05pm EST in the Exhibition Hall, this session will highlight innovative strategies and technological solutions that streamline processes and reduce overheads in signal detection and management.

"We are thrilled to be a part of this year's World Drug Safety Congress as a Gold Sponsor," said Raj Vaghela. "This event is a fantastic opportunity for us to showcase how PubHive’s robust technology can transform the safety and efficiency of drug safety and pharmacovigilance workflows, particularly benefiting small to medium-sized enterprises in the CROs and pharmaceutical industry."

Participants at the World Drug Safety Congress will have the opportunity to engage with PubHive’s experts at Booth #21, where they can experience live demonstrations and discussions about how PubHive can tailor its solutions to meet specific organizational needs.

PubHive is committed to providing innovative solutions that drive efficiency, collaboration, and productivity within the life science industry. For more information about PubHive Navigator and to explore its capabilities, please visit the PubHive website at https://pubhive.com. Details about the World Drug Safety Congress can be found here.

About World Drug Safety Congress Europe
The World Drug Safety Congress Europe is a leading industry event that brings together key players in pharmacovigilance and drug safety. The congress offers a platform for learning, networking, and discussing the latest trends and challenges in drug safety.

About PubHive
PubHive Ltd. is a cloud-based software company with a mission to make healthier scientific literature and safety workflows for life science companies across all stages of the commercialization lifecycle – from discovery to post-market. PubHive Navigator, the company’s scientific workflow management platform, optimizes existing business processes and automates repetitive work for teams in regulatory and medical affairs, research and development, drug safety, pharmacovigilance, medical devices, CER/PMCF, medical communication/writing, library, information management, document delivery, literature monitoring & reporting and other divisions. Powered by a proprietary Omni-Loop Artificial Intelligence (AI)™ engine, PubHive Navigator is the only 'fit for purpose' one-stop enterprise scientific workflow automation platform today, distinguishing itself through flexible end-to-end workstreams and intuitive interfaces that make literature handling quick and easy.